[ Price : $8.95]
AstraZeneca says a Phase 3 trial of its zibotentan in men with metastatic castration-resistant prostate cancer did not meet its pr...[ Price : $8.95]
FDA says hospital staff need to be aware that some devices in a manufacturers line may be sterile while other products are not.[ Price : $8.95]
Federal Register Notice: FDA sends a proposed collection of information on cGMPs for dietary supplements to the Office of Manageme...[ Price : $8.95]
Dismissing an FDA proposal to limit its review and approval of patient medication information, stakeholders urge the agency during...[ Price : $8.95]
Guided Therapeutics, Inc. files a PMA with FDA for the LightTouch Cervical Scanner for patients at risk for cervical cancer.[ Price : $8.95]
FDA and NIH are funding four regulatory science research projects over the next three years.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on premarket approval of devices to the Office of Manage...[ Price : $8.95]
FDA approves a Bayer HealthCare combination oral contraceptive containing a folate to counter neural tube defects in developing fe...